News

McDonald’s Corp. shares slipped on Tuesday after Redburn Atlantic gave the burger chain its sole sell rating, saying shifting ...
Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...
CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...
Lembas is a new b2b ingredient business that makes a peptide powder that targets the GLP-1 hormone for weight loss ...
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.
As costs continue to rise, employers are looking to the levers they have available to get their arms around this challenge, ...
Explore the upcoming GLP-1 surge and its impact on the global food and beverage industry. Discover challenges and opportunities amidst shifting consumer needs. Get insights and forecasts up to 2029, ...
GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...
While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...
Omada Health shares jumped after the company made its public-market debut, propelled by Americans’ renewed focus on how ...